Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-26

FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Original Application (Aurolife Pharma, LLC)

View source ↗

Summary

FDA approved a generic tablet containing butalbital, acetaminophen, and caffeine under ANDA204733 (Original Application) for Aurolife Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital; acetaminophen; caffeine)

Snippet

ORIG AP for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (BUTALBITAL, ACETAMINOPHEN AND CAFFEINE)